This Article Full Text Full Text (PDF) All Versions of this Article: 40/4/1262    most recent STROKEAHA.108.532085v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Urra, X. Articles by Chamorro, A. Search for Related Content PubMed PubMed Citation Articles by Urra, X. Articles by Chamorro, A. Related Collections Cell signalling/signal transduction Acute Cerebral Hemorrhage Acute Cerebral Infarction

(Stroke. 2009;40:1262.)
© 2009 American Heart Association, Inc.

Original Contributions

Monocytes Are Major Players in the Prognosis and Risk of Infection After Acute Stroke

Xabier Urra, MD; Álvaro Cervera, MD, PhD; Víctor Obach, MD; Núria Climent, PhD; Anna M. Planas, PhD Ángel Chamorro, MD, PhD

From Functional Unit of Cerebrovascular Diseases (X.U., A.C., V.O., A.C.), Hospital Clínic, Barcelona, Spain; Institut d’Investigations Biomediques August Pi i Sunyer (IDIBAPS) (N.C., A.M.P., A.C.), Barcelona, Spain; Service of Immunology (N.C.), Hospital Clínic, Barcelona, Spain; Institut d’Investigacions Biomèdiques de Barcelona (IIBB) (A.M.P.), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, Spain; Facultat de Medicina (A.C.), Universitat de Barcelona, Barcelona, Spain.

Correspondence to Ángel Chamorro, Institute of Neurosciences, 170 Villarroel, 08036 Barcelona, Spain. E-mail achamorro{at}ub.edu

Background and Purpose— Monocytes participate in adaptive and innate immune responses. Monocyte numbers increase in patients with stroke associated infection (SAI) or severe stroke. Whether changes in monocytes are related to specific effects, or simply mark brain damage, remains unsettled.

Methods— We used flow cytometry in 45 consecutive strokes and 12 healthy controls to assess the time course of monocytes, their phenotype, and the production of cytokines after stimulation. Cortisol, TNF-, IFN-, and IL-10 were measured in serum and metanephrine in plasma. The effects of humoral and cellular parameters on the risk of SAI and poor outcome were tested in multivariate analyses adjusted for confounders (NIHSS score, age, and tube feeding).

Results— Surface expression of human leukocyte antigen-DR, Toll-like receptor-2, and production of TNF- in monocytes were independently associated with stroke. Distinct immune mechanisms were related with functional outcome and the risk of SAI; the signature of SAI included an increase of cortisol, metanephrine, and IL-10 in serum, and reduced production of TNF- in monocytes; poor outcome was associated with increased expression of Toll-like receptor-4 in monocytes (OR, 9.61; 95% CI, 1.27–72.47). SAI did not predict poor outcome (OR, 5.63; 95% CI, 0.45–70.42; P=0.18).

Conclusions— In human stroke, poor outcome is associated to innate responses mediated by Toll-like receptor-4 in monocytes. SAI may result from the immunosuppressive and antiinflammatory effects of corticoids, catecholamines, IL-10, and deactivated monocytes. Early treated SAI does not contribute significantly to additional brain damage. These findings encourage the exploration of strategies aimed to inhibit Toll-like receptor-4 signaling in acute stroke.

Key Words: acute stroke • flow cytometry • immunology • monocytes • stroke-associated infection